Current status and future directions for the development of human papillomavirus vaccines. [PDF]
The development of human papillomavirus (HPV) vaccines has made substantive progress, as represented by the approval of five prophylactic vaccines since 2006.
Wang R +5 more
europepmc +2 more sources
Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. [PDF]
Objective To examine factors associated with parents’ uptake of human papillomavirus (HPV) vaccines for their children. Design Systematic review and meta-analysis.
Newman PA +7 more
europepmc +2 more sources
Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines.
Human papillomaviruses (HPVs) infect epithelial cells of human beings, and their replication cycle is associated with epithelial differentiation. More than 200 genotypes of HPVs were identified, and each of these HPVs shows distinct specificity for ...
A. Oyouni
semanticscholar +1 more source
BACKGROUND This objective of this umbrella review was to summarize the evidence on safety, efficacy, and effectiveness of human papillomavirus (HPV) vaccines in the general population.
A. Villa +7 more
semanticscholar +1 more source
Global challenges of implementing human papillomavirus vaccines
Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable.
Mishra Amrita, Graham Janice E
doaj +1 more source
Prophylactic HPV vaccines [PDF]
Human papillomavirus (HPV) is one of the most common sexually transmitted diseases worldwide. Cervical and other anogenital cancers, cervical and anal intraepithelial neoplasia, genital warts, and recurrent respiratory papillomatosis are HPV associated ...
Mandić Aljoša
doaj +1 more source
Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection. [PDF]
Human papillomavirus (HPV) infection is a frequent cause of malignant and non-malignant disease, in particular among persons with HIV. HPV serotype-specific anti L1 antibodies protect against HPV infection but little is known about prophylactic HPV ...
Zurek Munk-Madsen M +7 more
europepmc +2 more sources
Eliminat Cervical Cancer, Focusing on Primary Prevention
As one of the most severe malignant tumors, cervical cancer poses a significant threat to women. In 2020, the World Health Organization (WHO) introduced the "Global Strategy to Accelerate the Elimination of Cervical Cancer" in response to well ...
ZHAO Chao, LI Mingzhu, WEI Lihui
doaj +1 more source
Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
Introduction: Human papillomavirus is responsible for almost all cases of cervical cancer, an important portion of anogenital and oropharyngeal invasive and preinvasive lesions, as well as genital warts (condyloma acuminatum) and recurrent respiratory ...
Rita Medeiros +3 more
doaj +1 more source
A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]
Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel +5 more
doaj +1 more source

